van Tijn David A, de Vijlder Jan J M, Vulsma Thomas
Department of Pediatric Endocrinology, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands.
J Clin Endocrinol Metab. 2008 Oct;93(10):3794-803. doi: 10.1210/jc.2008-0492. Epub 2008 Jul 22.
The Dutch neonatal congenital hypothyroidism (CH) screening program detects infants with CH of central origin (CH-C). These infants have a high likelihood of multiple pituitary hormone deficiencies. ACTH deficiency especially poses an additional risk for brain damage and may be fatal.
Our objective was to evaluate different tools for assessment of the integrity of the hypothalamus-pituitary-adrenocortex (HPA) axis in young infants, aiming for a strategy for reliable and timely diagnosis.
DESIGN, SETTING: This is a Dutch nationwide prospective study (enrollment 1994-1996). Patients were included if neonatal CH screening results were indicative of CH-C and HPA axis function could be tested within 6 months of birth.
Nine male and three female infants with CH-C and four infants with false-positive screening results or transient hypothyroidism were included in the study.
CRH test results, multiple cortisol plasma concentrations, and cortisol excretion in 24-h urine were measured.
Six (50%) of the CH-C patients had abnormal CRH test results. Three of them had discordant test results: impaired increase of plasma cortisol in response to CRH, despite substantial increase of plasma ACTH. The other three infants, with concordant impaired responses of both ACTH and cortisol to CRH, had a very low urinary cortisol excretion in comparison with the subjects with normal CRH test results.
The CRH test proves to be a fast and reliable tool in the assessment of HPA axis (dys)function. It enables timely diagnosis in (asymptomatic) neonates at risk for serious morbidity and mortality. The discordant response type, which has not been described before, may be an early phase of HPA axis dysfunction. Alternatively, patients with this response type may constitute a separate pathogenetic subset of HPA axis-deficient patients.
荷兰新生儿先天性甲状腺功能减退症(CH)筛查项目可检测出中枢性起源的CH(CH-C)患儿。这些患儿很可能存在多种垂体激素缺乏。促肾上腺皮质激素(ACTH)缺乏尤其会增加脑损伤风险,甚至可能致命。
我们的目的是评估不同工具对幼儿下丘脑-垂体-肾上腺皮质(HPA)轴完整性的评估,以寻求可靠且及时的诊断策略。
设计、地点:这是一项荷兰全国性的前瞻性研究(1994 - 1996年入组)。若新生儿CH筛查结果提示CH-C且出生后6个月内可检测HPA轴功能,则纳入研究对象。
9例男性和3例女性CH-C患儿以及4例筛查结果假阳性或患有短暂性甲状腺功能减退症的患儿纳入研究。
测量促肾上腺皮质激素释放激素(CRH)试验结果、多次血浆皮质醇浓度以及24小时尿皮质醇排泄量。
6例(50%)CH-C患儿的CRH试验结果异常。其中3例试验结果不一致:尽管血浆ACTH大幅升高,但血浆皮质醇对CRH的反应增强受损。另外3例患儿ACTH和皮质醇对CRH的反应均受损,与CRH试验结果正常的受试者相比,其尿皮质醇排泄量极低。
CRH试验被证明是评估HPA轴(功能)障碍的快速且可靠的工具。它能够对有严重发病和死亡风险的(无症状)新生儿进行及时诊断。这种之前未被描述过的不一致反应类型可能是HPA轴功能障碍的早期阶段。或者,具有这种反应类型的患者可能构成HPA轴缺乏患者中一个单独的致病亚组。